Cancer


Ruben Mesa, M.D., FACP, named executive director of the Mays Cancer Center

September 28, 2020

SAN ANTONIO (Sept. 28, 2020) — Ruben Mesa, MD, FACP, has been named executive director of the Mays Cancer Center. His appointment includes academic and research programming, as well as leading the cancer center’s patient care and clinical programs of the UT Health San Antonio MD Anderson affiliation. Dr. Mesa’s appointment broadens the scope of […]



Three leadership announcements

September 28, 2020

President William L. Henrich, MD, MACP, announces the promotion or appointment of three outstanding individuals at UT Health San Antonio.


OncLive: Dr. Mesa on Emerging Therapies in Myelofibrosis

September 24, 2020

Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses emerging therapies in myelofibrosis. Watch the interview.


Targeted Oncology: Treatment approaches become more individualized as field of myelofibrosis advances

September 21, 2020

In this interview, Ruben Mesa, MD, director of the Mays Cancer Center, shares highlights from his presentation on the role of JAK inhibitors in myelofibrosis during the first annual Texas Virtual MPN Workshop and Meeting. Read the story.


Congressional Hispanic Caucus Institute: Global Pandemics: Innovation for early detection and a coordinated response system

September 18, 2020

Ruben Mesa, MD, FACP, director of the Mays Cancer Center, was a guest on a panel during the Congressional Hispanic Caucus Institute’s 2020 Leadership Conference.


OncLive: Dr. Mesa on the Emergence of JAK Inhibitors in Myelofibrosis

September 15, 2020

In this interview, Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses the emergence of JAK inhibitors in myelofibrosis. Watch the interview.